Alembic to expand bulk drug business

MUMBAI: Alembic is planning to expand its bulk drug business to the highly regulated U.S. market by joining hands with certain U.S.-based formulators. As a first step in this direction, the company has filed four Drug Master Files (DMF) with the U.S. FDA. .

Recommended for you